In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibit...
In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy
About this item
Full title
Author / Creator
Publisher
India: Wolters Kluwer India Pvt. Ltd
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer India Pvt. Ltd
Subjects
More information
Scope and Contents
Contents
Glycogen synthase kinase 3 beta (GSK3 β) plays a key role in pathologic hyper phosphorylation of tau and plays an important role in the pathogenesis of Alzheimer's disease. In the present study, we have screened a set of potential hits in in silico platform to gain insight regarding binding profile with the target (GSK3 β) from molecular docking, A...
Alternative Titles
Full title
In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e4c4b27ebcea40d7943279a08faa033e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e4c4b27ebcea40d7943279a08faa033e
Other Identifiers
ISSN
2231-4040
E-ISSN
0976-2094
DOI
10.4103/japtr.JAPTR_178_19
